Risk assessments to prioritise maintenance frequency and calibration scope


Published on 04/12/2025

Risk Assessments to Prioritise Maintenance Frequency and Calibration Scope

Effective risk assessments are crucial for establishing maintenance frequency and determining calibration scope within the pharmaceutical industry. Adherence to regulatory standards, such as those outlined by the FDA in 21 CFR Parts 210 and 211, ensures the safety and efficacy of pharmaceutical products. This tutorial provides a step-by-step approach for pharma professionals in clinical operations, regulatory affairs, and medical affairs, focusing on preventive maintenance and calibration within the context of utility lifecycle management.

Understanding the Principles of Preventive Maintenance and Calibration

Preventive maintenance (PM) is a proactive approach designed to ensure that equipment remains in optimal condition, thus reducing the likelihood of

failure and minimizing downtime. In the pharmaceutical industry, PM is particularly critical due to the stringent regulatory requirements and the potential impact on product quality.

The calibration program ensures that measurement equipment is functioning accurately, which is essential for validating both product quality and compliance with regulatory standards. Calibration involves comparing the output of a measurement device against a known standard and determining if it is within acceptable limits, often defined by a tolerance range.

The integration of a computerized maintenance management system (CMMS) can streamline both the preventive maintenance and calibration process. A CMMS is a software solution that helps manage maintenance operations and can also facilitate better data tracking and documentation, which are essential for compliance with Good Manufacturing Practices (GMP).

Key Regulatory Frameworks

  • FDA Regulations: The FDA enforces regulations that require pharmaceutical companies to maintain their equipment adequately. Relevant regulations include 21 CFR Part 210 and 211, which emphasize the importance of quality assurance in maintaining pharmaceutical manufacturing.
  • EMA and MHRA Guidelines: The European Medicines Agency (EMA) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) provide similar expectations for maintenance and calibration under GMP guidelines.
See also  KPIs to judge success of re validation beyond simple pass rates

Understanding these regulations provides the foundation for effective maintenance and calibration practices within pharmaceutical operations.

Step 1: Risk Assessment for Maintenance Frequency

The first step in establishing an effective preventive maintenance program is conducting a risk assessment to prioritize maintenance frequency. A risk-based approach allows organizations to allocate resources more effectively and focus efforts on the most critical assets.

1. Identifying Critical Assets

Identify which pieces of equipment and systems are critical to maintaining overall product quality and compliance. This typically involves assessing their impact on the manufacturing process and understanding the potential risks associated with their failure.

2. Evaluating Risks

Assess the likelihood of failure and the potential impact of each critical asset’s failure on product quality and compliance. A risk matrix can be employed to evaluate the severity and likelihood of identified risks.

3. Determining Maintenance Frequency

Based on the risk assessment, develop a prioritization scheme that determines how often each asset should undergo preventive maintenance. Higher-risk devices or systems may require more frequent maintenance, while lower-risk systems can be maintained less frequently.

This can be documented within your CMMS to ensure that maintenance schedules are observed, and key performance indicators (KPIs) can be tracked for ongoing evaluation.

Step 2: Establishing a Calibration Program

Calibration ensures that instruments and equipment provide accurate measurements, thereby maintaining quality standards. The calibration program should be accurately integrated with preventive maintenance practices to ensure compliance and product quality.

1. Define Calibration Standards

Establish the standards and tolerances for each measuring device. This includes outlining acceptable ranges and the frequency of calibration based on the device’s function, criticality, and manufacturer recommendations.

2. Calibration Schedule Development

Utilizing the insights gained from the initial risk assessment, develop a calibration schedule that corresponds with the preventive maintenance timeline. This helps ensure that both preventive maintenance and calibration activities are performed concurrently whenever possible, thus optimizing resource utilization.

See also  Using CAPA metrics to prioritise resources and drive continuous improvement

3. Out of Tolerance Management

Define a clear process for addressing instruments found to be out of tolerance during calibration. This should include immediate corrective actions, re-calibration procedures, and investigation protocols to root out the causes of the discrepancies.

Step 3: Implementing Condition Monitoring and Predictive Maintenance

Condition monitoring involves continuously assessing the performance of assets to identify degradation or operational anomalies that may lead to failure.

1. Utilizing Condition Monitoring Technologies

Implement sensor technologies and data analytics to monitor the condition of critical assets in real time. This approach enhances the effectiveness of PM and can lead to predictive maintenance strategies that forecast when maintenance should occur rather than relying on set schedules alone.

2. Bridging Condition Monitoring with Maintenance Decisions

The data collected through condition monitoring should be integrated into the CMMS. This enhances the decision-making process by allowing for data-driven maintenance strategies that optimize scheduling, thereby reducing unplanned downtime and improving overall asset management.

Step 4: Monitoring PM KPIs and Continuous Improvement

Once the preventive maintenance and calibration strategies are in place, it is essential to monitor key performance indicators (KPIs) regularly.

1. Establishing PM KPIs

Core PM KPIs may include:

  • Mean Time Between Failures (MTBF)
  • Mean Time To Repair (MTTR)
  • Maintenance Cost per Asset
  • Compliance Rate for Scheduled Maintenance

2. Continuous Improvement Processes

Conduct regular reviews of the maintenance and calibration processes. Utilize the data from PM KPIs to identify trends, make informed decisions, and promote a culture of continuous improvement within the organization. This aligns with both regulatory expectations and good business practices.

Documentation and Compliance

Documenting maintenance and calibration activities is a critical component for compliance with regulatory standards. Ensure that all procedures, schedules, calibration records, and maintenance logs are easily accessible and clearly maintained.

1. Regulatory Documentation Requirements

According to 21 CFR Part 211.68, records must be maintained for equipment cleaning, maintenance, and calibration. In addition, 21 CFR Part 58 emphasizes the importance of record-keeping in non-clinical laboratory studies, which inherently supports quality assurance in the drug development process.

See also  Training mechanics, technicians and engineers on GMP expectations for PM and cal

2. Audit Preparations

Regular internal audits should be conducted to ensure adherence to documented processes and compliance with regulatory standards. An effective audit identifies gaps and facilitates the continuous improvement of maintenance and calibration practices.

Conclusion

Implementing a comprehensive preventive maintenance and calibration program, grounded in risk assessment, is vital for pharmaceutical operations. By prioritizing maintenance frequency and calibration scope, organizations can enhance product quality, ensure regulatory compliance, and improve operational efficiencies. Maintaining rigorous documentation, employing condition monitoring, and continuously reviewing processes are critical to sustaining improvements and adapting to industry standards.

For more information, refer to the official FDA guidance documents and related resources to ensure comprehensive compliance and best practices.